California Institute for Regenerative Medicine (CIRM) announced a nearly $27 million award to USC to help fund its new stem cell building.
A study led by a researcher at the University of Southern California has found a new model to explain how signals between cells in the embryo control limb development.
A new study by researchers at the University of Southern California (USC) has found evidence that supports gender-related differences in the development and survival of metastatic colon cancer.
Colorectal cancer is the third most-common cause of cancer-related death in men and women in the nation, and about 112,340 new cases of colon cancer will be diagnosed this year. Experts at the Keck School of Medicine of USC are available to offer insight on issues including research, prevention, causes and risk factors and surgical and other therapeutic treatments.
Since 1973, the USC/Norris Comprehensive Cancer Center has emerged as a major regional and national is a leader in cancer research, with nearly 200 members investigating the complex origins and progression of cancer, developing prevention strategies and searching for cures. USC/Norris is designated by the National Cancer Institute as one of the nation's 39 comprehensive cancer centers.
Between 1976 and 2000, breast cancer was the most common cancer among women in Los Angeles County, regardless of their race or ethnicity, according to research by the Los Angeles Cancer Surveillance Program at the USC/Norris Comprehensive Cancer Center and the Keck School of Medicine of USC. Staff from the USC/Norris Comprehensive Cancer Center and Hospital are available to share their expertise on all matters related to breast cancer.
Combined positron emission tomography (PET) and computed tomography (CT) imaging of lymphoma patients is a more effective method to evaluate response to radiation therapy, and may help patients avoid unnecessary follow-up treatments, a study by researchers at the University of Southern California (USC) suggests.
A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12).
Instead of a silver bullet to kill cancer cells, USC biologists discover a way to protect all other cells against chemotherapy. Experts call the animal study a major advance in cancer research.
Researchers at the University of Southern California (USC) have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease.
A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12).
Multi-million dollar gift to USC from long-time cancer research supporter.
Combined positron emission tomography (PET) and computed tomography (CT) imaging of lymphoma patients is a more effective method to evaluate response to radiation therapy, and may help patients avoid unnecessary follow-up treatments, a study by researchers at the University of Southern California (USC) suggests.
Researchers at the University of Southern California (USC) have uncovered a new way to develop more effective tumor vaccines by turning off the suppression function of regulatory T cells.
Researchers at the University of Southern California (USC) have identified a novel cyclic signaling in the dermis that coordinates stem cell activity and regulates regeneration in large populations of hairs in animal models.
University of Southern California surgeon Namir Katkhouda, M.D., will be inducted into the Knighthood of the French Legion of Honor for his pioneering work in laparoscopic surgery. He will receive the honor from the French Ambassador to the United States, Pierre Vimont, during a formal ceremony at USC.
The largest gift ever given to the USC/Norris Comprehensive Cancer Center-$60 million- was made today towards the university's hematology program.
Researchers at the University of Southern California (USC) suggest epigenetics, or the way DNA is processed and expressed, may be the underlying cause for male infertility.
The University of Southern California installed Dr. Carmen Puliafito, Tuesday, as dean of the Keck School of Medicine.
New collaboration created between Southern California institutions for research into stem cells. Institutions include: USC, Childrens Hospital Los Angeles, House Ear Institute, City of Hope, Caltech and UC Santa Barbara.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right